Abstract:Objectives To investigate the underlying mechanisms of scalp acupuncture treatment (SAT) on autism spectrum disorder (ASD). Methods Thirty male Wistar rat pups that had been prenatally exposed to valproic acid sodium (VPA) were randomly divided into the VPA, VPA+acupoint, and VPA+ non-acupoint groups using the random number table method, with 10 rats in each group. Ten pups who had been prenatally exposed to saline were assigned to the control group (CG). There was no intervention in either the control or VPA groups. In the acupoint group, "Shenting (GV24)," bilateral "Benshen (GB13)" were manipulated. In the non-acupoint group, the area below the costal space was stimulated. Acupuncture stimulation lasted for 40 min, with manual twisting of the needles every 10 min, 5 days/week, with 2 days of rest per week, for a total duration of 4 weeks. After the corresponding treatments, behavioral tests (including the open field, social interaction, and Morris water maze tests) were performed to evaluate the therapeutic effects. RT-PCR and Western blotting were performed to detect the expression of neuregulin 1 (NRG1)/ErbB4. Results In the open field test, the activity time spent in the central area in the VPA+acupoint group was significantly longer than that in the VPA group and VPA+ non-acupoint group (both P <0.05). The total length in the VPA+acupoint group was significantly longer than that in the VPA group ( P <0.05). The number of bouts in the central area of the VPA+acupoint group was significantly higher than that of the VPA group ( P <0.05). In session I of social interaction test, all experimental rats spent more time interacting with stranger 1 (all P <0.05). In session II, the CG and VPA+acupoint groups rats showed more interest in searching for new strangers, but the VPA+non-acupoint group spent more time interacting with stranger 1 than with stranger 2(all P <0.05). In the Morris water maze test, compared with the VPA group, the latency of the VPA+acupoint group was shorter (day 2, 3, 4, 5, P <0.05); compared with VPA+acupoint group, the latency of the VPA+non-acupoint group was longer (day 2, 4, P <0.05). The mean distance in the VPA+acupoint group was shorter than that in the VPA group (day 3, 5, P <0.05). The platform quadrant time of the VPA+non-acupoint group was significantly shorter than that of the VPA+acupoint group ( P <0.05) (day 6). The VPA+acupoint group had more platform crossings than the VPA group ( P <0.05), and the VPA+ non-acupoint group had fewer platform crossings than the VPA+acupoint group ( P <0.05) (day 6). After SAT, the expression levels of NRG1 and ErbB4 proteins in the VPA+acupoint group were significantly increased than those in the VPA group (both P <0.05) in the medial prefrontal cortex (mPFC). The expression levels of NRG1 and ErbB4 proteins in VPA+non-acupoint group were significantly less than those in the VPA+acupoint group (both P <0.05) in the mPFC. After SAT, the expression levels of NRG1 and ErbB4 proteins in the VPA+acupoint group were significantly higher than those in the VPA group (both P <0.05) in the hippocampus. The expression levels of NRG1 and ErbB4 proteins in the VPA+non-acupoint group were significantly lower than those in the VPA+acupoint group (both P <0.05) in the hippocampus. After SAT, the expression levels of mRNA levels of NRG1-ErbB4 in the mPFC and hippocampus in VPA+acupoint group were significantly higher than those in the VPA group (all P <0.05). The mRNA expression levels of NRG1-ErbB4 in the mPFC and hippocampus in VPA+ non-acupoint group were significantly lower than those in the VPA+acupoint group (all P <0.05). Conclusions Our results suggest that SAT can improve ASD-like behaviors in young rats in a VPA model of ASD. This may be related to its function in upregulating the expression of protein and gene of NRG1 and its receptor ErbB4 in the mPFC.

The expression of the PV-immunopositive neurons in the brain regions associated with emotion and cognition in animal models of autism

Expression Of The Pv- And Bdnf-Immunoreactive Neurons In The Brain Regions Associated With Emotion And Cognition In Animal Models Of Autism

Age-related changes of parvalbumin expression in superior colliculus of prenatal valproate exposure rats

Altered Relationship Between Parvalbumin and Perineuronal Nets in an Autism Model

The expression of BDNF-immunoreactive neurons in the parietal sensory cortex in animal model of autism of rat

The Role of Parvalbumin Interneurons in Autism Spectrum Disorder

Abnormal expression of epigenetic factors in the hippocampus of prenatal valproic acid exposure autistic rat model

Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities

Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model

VPA-induced autism impairs memory ability through disturbing neural oscillatory patterns in offspring rats

The Parvalbumin Hypothesis of Autism Spectrum Disorder

Dysregulation of Parvalbumin Expression in the Cntnap2−/− Mouse Model of Autism Spectrum Disorder

Scalp Acupuncture improves disordered behavior in the valproic acid-induced rat model of autism

Preface: Twenty Years of the QED Manifesto

Emerging Mechanisms of Valproic Acid-Induced Neurotoxic Events in Autism and Its Implications for Pharmacological Treatment

Transcriptome Analysis and Epigenetics Regulation in the Hippocampus and the Prefrontal Cortex of VPA-Induced Rat Model

Reduced excitatory activity in the developing mPFC mediates a PVH-to-PVL transition and impaired social cognition in autism spectrum disorders

Changes of canonical Wnt signaling pathway in brains of rats with autism induced by prenatal exposure to valproic acid

Deletions of Cacna2d3 in parvalbumin-expressing neurons leads to autistic-like phenotypes in mice

Dysregulation of parvalbumin expression and neurotransmitter imbalance in the auditory cortex of the BTBR mouse model of autism spectrum disorder

Autistic-like behaviour and changes in thalamic cell numbers a rat model of valproic acid-induced autism; A behavioural and stereological study